ARTICLE | Company News
Gilead, Spring Bank deal
December 7, 2015 8:00 AM UTC
The companies partnered to conduct a Phase II trial of Spring Bank’s SB 9200 in combination with Gilead’s Viread tenofovir disoproxil fumarate to treat HBV infection. The partners did not respond to...